Ongoing and unsaid on oxaliplatin: the hope
1998

Oxaliplatin: A New Hope for Cancer Treatment

Sample size: 25 publication Evidence: moderate

Author Information

Author(s): E Cvitkovic

Primary Institution: SMST Hopital Paul Brousse, Villejuif, France

Hypothesis

Oxaliplatin may be effective in treating cancers resistant to traditional platinum-based therapies.

Conclusion

Oxaliplatin shows high effectiveness in treating advanced colorectal and ovarian cancers, and it may also be beneficial for other types of cancer.

Supporting Evidence

  • Oxaliplatin has shown effectiveness in colorectal cancer as first-line therapy.
  • It has been effective in patients with ovarian cancer who were resistant to platinum compounds.
  • Oxaliplatin has a good safety profile, making it suitable for combination therapies.
  • Early results suggest oxaliplatin may also be effective in non-Hodgkin's lymphoma, breast, and non-small-cell lung cancers.

Takeaway

Oxaliplatin is a new cancer drug that works well for patients whose cancer doesn't respond to older treatments.

Methodology

The study involved various trials assessing the effectiveness of oxaliplatin in different cancer types, including colorectal and ovarian cancers.

Limitations

The results are based on preliminary data and ongoing trials, with full potential yet to be explored.

Participant Demographics

Patients included those with advanced colorectal and ovarian cancers, some of whom were resistant to previous treatments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication